Food Allergy Market Size, Share, and Trends 2026 to 2035

Chapter 1. Introduction

1.1. Research Objective

1.2. Scope of the Study

1.3. Definition

Chapter 2. Research Methodology

2.1. Research Approach

2.2. Data Sources

2.3. Assumptions & Limitations

Chapter 3. Executive Summary

3.1. Market Snapshot

Chapter 4. Market Variables and Scope 

4.1. Introduction

4.2. Market Classification and Scope

4.3. Industry Value Chain Analysis

4.3.1. Raw Material Procurement Analysis 

4.3.2. Sales and Distribution Channel Analysis

4.3.3. Downstream Buyer Analysis

Chapter 5. COVID 19 Impact on Food Allergy Market 

5.1. COVID-19 Landscape: Food Allergy Industry Impact

5.2. COVID 19 - Impact Assessment for the Industry

5.3. COVID 19 Impact: Global Major Government Policy

5.4. Market Trends and Opportunities in the COVID-19 Landscape

Chapter 6. Market Dynamics Analysis and Trends

6.1. Market Dynamics

6.1.1. Market Drivers

6.1.2. Market Restraints

6.1.3. Market Opportunities

6.2. Porter’s Five Forces Analysis

6.2.1. Bargaining power of suppliers

6.2.2. Bargaining power of buyers

6.2.3. Threat of substitute

6.2.4. Threat of new entrants

6.2.5. Degree of competition

Chapter 7. Competitive Landscape

7.1.1. Company Market Share/Positioning Analysis

7.1.2. Key Strategies Adopted by Players

7.1.3. Vendor Landscape

7.1.3.1. List of Suppliers

7.1.3.2. List of Buyers

Chapter 8. Global Food Allergy Market, By Allergen Type

8.1. Food Allergy Market Revenue and Volume, by Allergen Type

8.1.1 Peanut Allergy 

8.1.1.1. Market Revenue and Volume Forecast

8.1.2. Milk Allergy 

8.1.2.1. Market Revenue and Volume Forecast

8.1.3. Egg Allergy 

8.1.3.1. Market Revenue and Volume Forecast

8.1.4. Tree Nut Allergy 

8.1.4.1. Market Revenue and Volume Forecast

8.1.5. Fish & Shellfish Allergy 

8.1.5.1. Market Revenue and Volume Forecast

8.1.6. Soy Allergy 

8.1.6.1. Market Revenue and Volume Forecast

8.1.7. Wheat/Sesame & Others

8.1.7.1. Market Revenue and Volume Forecast

Chapter 9. Global Food Allergy Market, By Product/Treatment Type

9.1. Food Allergy Market Revenue and Volume, by Product/Treatment Type

9.1.1. Diagnostics (tests) 

9.1.1.1. Market Revenue and Volume Forecast

9.1.2. therapeutics 

9.1.2.1. Market Revenue and Volume Forecast

9.1.3. Epinephrine Auto-Injectors 

9.1.3.1. Market Revenue and Volume Forecast

9.1.4. Antihistamines & Others

9.1.4.1. Market Revenue and Volume Forecast

Chapter 10. Global Food Allergy Market, By End-User/Channel

10.1. Food Allergy Market Revenue and Volume, by End-User/Channel

10.1.1. Hospitals & Clinics 

10.1.1.1. Market Revenue and Volume Forecast

10.1.2. Diagnostic Laboratories 

10.1.2.1. Market Revenue and Volume Forecast

10.1.3. Home Care & Pharmacies 

10.1.3.1. Market Revenue and Volume Forecast

10.1.4. Research Institutes

10.1.4.1. Market Revenue and Volume Forecast

Chapter 11. Global Food Allergy Market, Regional Estimates and Trend Forecast

11.1. North America

11.1.1. Market Revenue and Volume Forecast, by Allergen Type

11.1.2. Market Revenue and Volume Forecast, by Product/Treatment Type

11.1.3. Market Revenue and Volume Forecast, by End-User/Channel

11.1.4. U.S.

11.1.4.1. Market Revenue and Volume Forecast, by Allergen Type

11.1.4.2. Market Revenue and Volume Forecast, by Product/Treatment Type

11.1.4.3. Market Revenue and Volume Forecast, by End-User/Channel

11.1.5. Rest of North America

11.1.5.1. Market Revenue and Volume Forecast, by Allergen Type

11.1.5.2. Market Revenue and Volume Forecast, by Product/Treatment Type

11.1.5.3. Market Revenue and Volume Forecast, by End-User/Channel

11.2. Europe

11.2.1. Market Revenue and Volume Forecast, by Allergen Type

11.2.2. Market Revenue and Volume Forecast, by Product/Treatment Type

11.2.3. Market Revenue and Volume Forecast, by End-User/Channel

11.2.4. UK

11.2.4.1. Market Revenue and Volume Forecast, by Allergen Type

11.2.4.2. Market Revenue and Volume Forecast, by Product/Treatment Type

11.2.4.3. Market Revenue and Volume Forecast, by End-User/Channel

11.2.5. Germany

11.2.5.1. Market Revenue and Volume Forecast, by Allergen Type

11.2.5.2. Market Revenue and Volume Forecast, by Product/Treatment Type

11.2.5.3. Market Revenue and Volume Forecast, by End-User/Channel

11.2.6. France

11.2.6.1. Market Revenue and Volume Forecast, by Allergen Type

11.2.6.2. Market Revenue and Volume Forecast, by Product/Treatment Type

11.2.6.3. Market Revenue and Volume Forecast, by End-User/Channel

11.2.7. Rest of Europe

11.2.7.1. Market Revenue and Volume Forecast, by Allergen Type

11.2.7.2. Market Revenue and Volume Forecast, by Product/Treatment Type

11.2.7.3. Market Revenue and Volume Forecast, by End-User/Channel

11.3. APAC

11.3.1. Market Revenue and Volume Forecast, by Allergen Type

11.3.2. Market Revenue and Volume Forecast, by Product/Treatment Type

11.3.3. Market Revenue and Volume Forecast, by End-User/Channel

11.3.4. India

11.3.4.1. Market Revenue and Volume Forecast, by Allergen Type

11.3.4.2. Market Revenue and Volume Forecast, by Product/Treatment Type

11.3.4.3. Market Revenue and Volume Forecast, by End-User/Channel

11.3.5. China

11.3.5.1. Market Revenue and Volume Forecast, by Allergen Type

11.3.5.2. Market Revenue and Volume Forecast, by Product/Treatment Type

11.3.5.3. Market Revenue and Volume Forecast, by End-User/Channel

11.3.6. Japan

11.3.6.1. Market Revenue and Volume Forecast, by Allergen Type

11.3.6.2. Market Revenue and Volume Forecast, by Product/Treatment Type

11.3.6.3. Market Revenue and Volume Forecast, by End-User/Channel

11.3.7. Rest of APAC

11.3.7.1. Market Revenue and Volume Forecast, by Allergen Type

11.3.7.2. Market Revenue and Volume Forecast, by Product/Treatment Type

11.3.7.3. Market Revenue and Volume Forecast, by End-User/Channel

11.4. MEA

11.4.1. Market Revenue and Volume Forecast, by Allergen Type

11.4.2. Market Revenue and Volume Forecast, by Product/Treatment Type

11.4.3. Market Revenue and Volume Forecast, by End-User/Channel

11.4.4. GCC

11.4.4.1. Market Revenue and Volume Forecast, by Allergen Type

11.4.4.2. Market Revenue and Volume Forecast, by Product/Treatment Type

11.4.4.3. Market Revenue and Volume Forecast, by End-User/Channel

11.4.5. North Africa

11.4.5.1. Market Revenue and Volume Forecast, by Allergen Type

11.4.5.2. Market Revenue and Volume Forecast, by Product/Treatment Type

11.4.5.3. Market Revenue and Volume Forecast, by End-User/Channel

11.4.6. South Africa

11.4.6.1. Market Revenue and Volume Forecast, by Allergen Type

11.4.6.2. Market Revenue and Volume Forecast, by Product/Treatment Type

11.4.6.3. Market Revenue and Volume Forecast, by End-User/Channel

11.4.7. Rest of MEA

11.4.7.1. Market Revenue and Volume Forecast, by Allergen Type

11.4.7.2. Market Revenue and Volume Forecast, by Product/Treatment Type

11.4.7.3. Market Revenue and Volume Forecast, by End-User/Channel

11.5. Latin America

11.5.1. Market Revenue and Volume Forecast, by Allergen Type

11.5.2. Market Revenue and Volume Forecast, by Product/Treatment Type

11.5.3. Market Revenue and Volume Forecast, by End-User/Channel

11.5.4. Brazil

11.5.4.1. Market Revenue and Volume Forecast, by Allergen Type

11.5.4.2. Market Revenue and Volume Forecast, by Product/Treatment Type

11.5.4.3. Market Revenue and Volume Forecast, by End-User/Channel

11.5.5. Rest of LATAM

11.5.5.1. Market Revenue and Volume Forecast, by Allergen Type

11.5.5.2. Market Revenue and Volume Forecast, by Product/Treatment Type

11.5.5.3. Market Revenue and Volume Forecast, by End-User/Channel

Chapter 12. Company Profiles

12.1. Sanofi S.A.

12.1.1. Company Overview

12.1.2. Product Offerings

12.1.3. Financial Performance

12.1.4. Recent Initiatives

12.2. Pfizer Inc.

12.2.1. Company Overview

12.2.2. Product Offerings

12.2.3. Financial Performance

12.2.4. Recent Initiatives

12.3. GSK plc 

12.3.1. Company Overview

12.3.2. Product Offerings

12.3.3. Financial Performance

12.3.4. Recent Initiatives

12.4. Mylan N.V. / Viatris 

12.4.1. Company Overview

12.4.2. Product Offerings

12.4.3. Financial Performance

12.4.4. Recent Initiatives

12.5. Novartis AG

12.5.1. Company Overview

12.5.2. Product Offerings

12.5.3. Financial Performance

12.5.4. Recent Initiatives

12.6. Teva Pharmaceutical Industries Ltd.

12.6.1. Company Overview

12.6.2. Product Offerings

12.6.3. Financial Performance

12.6.4. Recent Initiatives

12.7. Bayer AG

12.7.1. Company Overview

12.7.2. Product Offerings

12.7.3. Financial Performance

12.7.4. Recent Initiatives

12.8. Merck & Co., Inc. 

12.8.1. Company Overview

12.8.2. Product Offerings

12.8.3. Financial Performance

12.8.4. Recent Initiatives

12.9. Aimmune Therapeutics

12.9.1. Company Overview

12.9.2. Product Offerings

12.9.3. Financial Performance

12.9.4. Recent Initiatives

12.10. Allergy Therapeutics PLC

12.10.1. Company Overview

12.10.2. Product Offerings

12.10.3. Financial Performance

12.10.4. Recent Initiatives

Chapter 13. Research Methodology

13.1. Primary Research

13.2. Secondary Research

13.3. Assumptions

Chapter 14. Appendix

14.1. About Us

14.2. Glossary of Terms